Autolytic properties of glycopeptide-intermediate Staphylococcus aureus Mu50

Antimicrob Agents Chemother. 2006 Apr;50(4):1541-5. doi: 10.1128/AAC.50.4.1541-1545.2006.

Abstract

Whole-cell autolytic activity of prototypical glycopeptide-intermediate Staphylococcus aureus (GISA) Mu50 was reduced versus that of hetero-GISA Mu3 and glycopeptide-susceptible S. aureus, consistent with other GISA strains. In contrast, autolytic activity was relatively high in Mu50 crude cell walls and autolysin extracts against purified cell walls, reflecting the complexities of autolytic activity regulation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacteriolysis / drug effects*
  • Glycopeptides / metabolism
  • Glycopeptides / pharmacology*
  • Microbial Sensitivity Tests
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / metabolism
  • Vancomycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Glycopeptides
  • Vancomycin